Vaccines and Related Biological Products Advisory Committee Meeting

Vaccines and Related Biological Products Advisory Committee Meeting Committee meeting February 27, 2013 between approximately 8:30 a.m. and 2:45 p.m. Agenda: On February 27, 2013, the committee will meet in open session to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccine for the 2013-2014 influenza season.

Impact of Approved Drug Labeling on Chronic Opioid Therapy

Impact of Approved Drug Labeling on Chronic Opioid Therapy The public hearing will be held on February 7 and 8, 2013, from 9 a.m. to 4 p.m. (Day 2 of 2) The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.

Impact of Approved Drug Labeling on Chronic Opioid Therapy

Impact of Approved Drug Labeling on Chronic Opioid Therapy The public hearing will be held on February 7 and 8, 2013, from 9 a.m. to 4 p.m. (Day 1 of 2) The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain.